Addus HomeCare’s (ADUS) Outperform Rating Reaffirmed at Royal Bank of Canada

Royal Bank of Canada restated their outperform rating on shares of Addus HomeCare (NASDAQ:ADUS) in a research report sent to investors on Thursday,Benzinga reports. They currently have a $136.00 price objective on the stock.

Other equities research analysts also recently issued research reports about the company. Stephens boosted their price objective on Addus HomeCare from $143.00 to $145.00 and gave the company an “overweight” rating in a report on Wednesday, November 6th. Oppenheimer boosted their price target on shares of Addus HomeCare from $140.00 to $145.00 and gave the company an “outperform” rating in a research note on Monday, September 23rd. KeyCorp assumed coverage on shares of Addus HomeCare in a research note on Friday, October 11th. They issued an “overweight” rating and a $150.00 price objective on the stock. Macquarie reissued an “outperform” rating and set a $139.00 target price on shares of Addus HomeCare in a research report on Monday, November 4th. Finally, TD Cowen upped their target price on shares of Addus HomeCare from $128.00 to $137.00 and gave the stock a “buy” rating in a report on Thursday, August 8th. One research analyst has rated the stock with a sell rating, eight have issued a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $131.63.

Addus HomeCare Price Performance

Shares of NASDAQ:ADUS traded down $1.92 during mid-day trading on Thursday, hitting $120.15. The company had a trading volume of 41,577 shares, compared to its average volume of 131,245. The company has a market capitalization of $2.18 billion, a PE ratio of 27.93, a price-to-earnings-growth ratio of 2.15 and a beta of 1.04. Addus HomeCare has a one year low of $85.43 and a one year high of $136.12. The firm has a fifty day moving average price of $129.12 and a 200 day moving average price of $122.06.

Addus HomeCare (NASDAQ:ADUS) last announced its quarterly earnings data on Monday, November 4th. The company reported $1.30 earnings per share for the quarter, beating the consensus estimate of $1.28 by $0.02. The firm had revenue of $289.80 million for the quarter, compared to analyst estimates of $289.42 million. Addus HomeCare had a net margin of 6.50% and a return on equity of 9.62%. The business’s quarterly revenue was up 7.1% compared to the same quarter last year. During the same quarter in the prior year, the business earned $1.03 earnings per share. Research analysts expect that Addus HomeCare will post 4.58 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other news, EVP Michael D. Wattenbarger sold 21,917 shares of the firm’s stock in a transaction that occurred on Monday, August 26th. The shares were sold at an average price of $133.29, for a total value of $2,921,316.93. Following the transaction, the executive vice president now owns 7,215 shares in the company, valued at approximately $961,687.35. This trade represents a 75.23 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Esteban Lopez sold 500 shares of the business’s stock in a transaction dated Tuesday, September 10th. The shares were sold at an average price of $127.50, for a total transaction of $63,750.00. Following the completion of the transaction, the director now owns 3,366 shares in the company, valued at $429,165. The trade was a 12.93 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 22,917 shares of company stock valued at $3,050,082 in the last quarter. Corporate insiders own 4.60% of the company’s stock.

Institutional Investors Weigh In On Addus HomeCare

Several institutional investors and hedge funds have recently modified their holdings of ADUS. BNP Paribas Financial Markets raised its stake in Addus HomeCare by 20.3% during the first quarter. BNP Paribas Financial Markets now owns 11,854 shares of the company’s stock valued at $1,225,000 after buying an additional 2,000 shares during the last quarter. Empowered Funds LLC increased its holdings in shares of Addus HomeCare by 9.8% in the 1st quarter. Empowered Funds LLC now owns 6,890 shares of the company’s stock worth $712,000 after purchasing an additional 615 shares in the last quarter. Russell Investments Group Ltd. raised its stake in shares of Addus HomeCare by 9.3% in the first quarter. Russell Investments Group Ltd. now owns 46,764 shares of the company’s stock worth $4,833,000 after purchasing an additional 3,997 shares during the last quarter. ProShare Advisors LLC lifted its holdings in shares of Addus HomeCare by 7.3% during the first quarter. ProShare Advisors LLC now owns 3,163 shares of the company’s stock valued at $327,000 after purchasing an additional 214 shares in the last quarter. Finally, Entropy Technologies LP bought a new stake in Addus HomeCare in the 1st quarter worth about $258,000. 95.35% of the stock is owned by hedge funds and other institutional investors.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.